Macular degeneration other diagnostic studies

Macular degeneration Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Macular Degeneration from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Macular degeneration other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Macular degeneration other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Macular degeneration other diagnostic studies
CDC on Macular degeneration other diagnostic studies
Macular degeneration other diagnostic studies in the news
Blogs on Macular degeneration other diagnostic studies
Directions to Hospitals Treating Macular degeneration
Risk calculators and risk factors for Macular degeneration other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Fluorescein angiography allows for the identification and localization of abnormal vascular processes. Optical coherence tomography is now used by most ophthalmologists in the diagnosis and the followup evaluation of the response to treatment by using either Avastin or Lucentis which are injected into the vitreous of the eye at various intervals.